With increasing chronic diseases, demand for personalized medicines, and adoption of AI, the biotech market is booming.

Boston is not just a hub for history buffs and sports enthusiasts; it’s also a powerhouse of innovation that propels the ...

Welcome to the heart of biotech brilliance! Nestled along the Charles River, Boston has transformed itself from a city known ...

The broad field of biotechnology and applied microbiology covers topics on the manipulation of living organisms to make products or solve problems to meet human needs. Students in this field study ...

VIR's HDV and HBV treatments remain Vir's primary value drivers, with upcoming catalysts in Q4 2024 and 2025. Find out why ...

Equitable Trust Co. lifted its stake in Repligen Co. (NASDAQ:RGEN – Free Report) by 52.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund ...

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013.

This week brought opportunities and challenges for the zodiac signs in their careers. While some signs thrived in fast-paced ...

Avidian Wealth Enterprises LLC lifted its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 13.6% during the ...

Given this risk, we thought we'd take a look at whether Sana Biotechnology (NASDAQ:SANA) shareholders should be worried about its cash burn. In this report, we will consider the company's annual ...

Let’s look at where Sana Biotechnology, Inc. (SANA) stands against other penny stocks with the biggest upside potential. The Federal Reserve slashed interest rates by a half point in September ...